...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Applied Drug Research, Clinical Trials and Regulatory Affairs. >Skirmishing Disconcerting Covid-19 by Drug Reassigning
【24h】

Skirmishing Disconcerting Covid-19 by Drug Reassigning

机译：冲突不安Covid-19药物重新分配

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: COVID-19 is a most life threatening condition, therefore it is declared a pandemic by WHO as it has affected the whole world. Even though there are many advanced drug discoveries, viral afflictions are a broad area for researchers. Unfortunately, to date, no drug can treat this lethal infection. COVID -19 has raised the death rate crucially; therefore, it needs the reassigning of drugs for the control of affliction. In some cases, it shows that drug reassigning may cause adverse reactions. But in some countries, these drugs manifest fruitful effects for COVID patients. This article focuses on the effective drug moieties found in in-vitro studies. These drug moieties need further clinical testing based on their in-vitro clinical data. These moieties have shown hope as promising drugs for treating the deadly infection.Objectives: The current manuscript is prepared with the main objectives of studying the various drugs and their benefits for the preparation of a vaccine for COVID-19 pandemics and studying the clinical trial status of drugs that are in the final stage of vaccine development.Discussion and Conclusion: The vaccine development process is in progress, and has almost reached the final stage. There are drug reassignments for suppressing the COVID-19 by using various drugs such as Remdesivir, Sarilumab, Favipiravir, Tocilizumab, etc.; the whole world suffered a huge loss due to this pandemic, and the wait for the vaccine will be over shortly.
机译：背景:COVID-19最威胁生命条件,因此宣布大流行他影响了整个世界。虽然有许多先进的药物的发现,病毒性疾病是一个广泛的领域研究人员。治疗这种致命的感染。死亡率至关重要;重新分配的药物控制苦难。重新分配可能会引起不良反应。一些国家,这些药物清单卓有成效COVID患者的影响。有效的药物在体外发现半个研究。基于体外临床临床测试数据。药物治疗致命的感染。准备研究的主要目标各种药物和他们的利益COVID-19大流行疫苗的准备与研究药物的临床试验状态在最后阶段的疫苗发展。疫苗开发过程正在进行中几乎已经到了最后阶段。药物抑制COVID-19重新分配通过使用各种药物如Remdesivir,Sarilumab Favipiravir,叫等;世界遭受了巨大的损失大流行,等待疫苗在不久。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号